Mikhail Blagoklonny Shows us the Fountain of Youth
According to oncologist Mikhail Blagosklonny, there was a time not too long ago that medical professionals believed that the aging process of the human body was a function of molecules breaking down and slowly moving towards decay. The theory was that this process was unavoidable and therefore could not be prevented. Then a new theory came along, supported by Mikhail, to challenge this. This theory said that aging is not just a function of molecular breakdown but the continuous growth of the body. The theory further suggested that TOR or Target of Rapamycin was a possible treatment for cancer aging thereby getting rid of aging-related health issues. What would be done is Rapamycin would be administered to patients in specific doses to give humans a healthier life span.
However, there were skeptics to this approach and it was even ridiculed. Despite this setback proponents of Rapamycin predicted that it would be the go-to cure for aging-related health issues in a few years. Today, this prediction has come true and the TOR centric method is pretty much taken for granted to treat this area of health. Needless to say, this became big news in the medical world and was quickly dubbed the “fountain of youth” drug. Of course, all this progress raises interesting questions such as how will people pass away in the future?Mikhail Blagosklonny is a noted oncologist and teaches at Roswell Park Cancer Institute and does research on aging as well as various types of cancers. He got his MD degree in Internal medicine and PhD in Experimental Medicine and Cardiology at First Pavlov State Medical University in St. Petersburg, Russia. He moved to New York in 2002 and joined New York Medical College as a professor in Associate medicine. He also worked at Ordway Research Institute as a senior researcher. Seven years later he joined Roswell Park Cancer Institute as professor of Oncology. It is all this exposure in both the academic as well as the research side of things that has made him the excellent teacher he is today and is also the reason why he works as editor-in-chief of Oncotarget.
Oncotarget is a peer-reviewed, multidisciplinary, online cancer magazine that is available once a week for free. The disciplines other than oncology the magazine covers are Cardiology, metabolism, Cell Biology, Neuroscience, Endocrinology, and Pharmacology. Apart from working for Oncotarget Mikhail also contributes for Cell Cycle and Cancer Biology and Therapy. However, one of his biggest areas of interest is in Biogerontology or the science of aging. It was during his studies in this field that he reached the hypothesis regarding the link between TOR signaling and aging along with cancer. This is when he suggested that using Rapamycin would be a deterrent for aging. Rapamycin is a widely used drug in the treatment of cancer.Apart from all this work, Mikhail has authored a book on aging hyperfunction theory. He has over 300 articles covering a wide range of subjects in medical science to his credit. He is also a firm believer that cancer is a curable disease which can be done through treatment using Rapamycin.